The results of a study being published in the New England Journal of Medicine are favorable toward a blood test that helps doctors detect a particular type of cancer -- a good sign for biotech startup Grail as it further develops the test. The startup's investors include pharmaceutical company Merck and China's Tencent, as well as Bill Gates and Jeff Bezos.
Merck-backed startup makes progress on blood test for cancer
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.